AMN Healthcare Services Pulled From Avondale's Conviction Buy List, Reserved For More Patient Investors


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


Avondale Partners' Randle Reece removed AMN Healthcare Services, Inc. (NYSE: AHS) from the firm's conviction list while raising the company's price objective from $42.00 to $43.00.

The list was directed toward short-term investments driven by "specific catalysts," and AMN Healthcare Services does not fit that description according to Reece. "We find the stock to be suitable for more patient investors," said the analyst.

Reece did acknowledge that "AHS is the leading company in a segment of the US staffing market that is growing much faster than any other." The EV/EBITDA premium is "unusually wide," however, and increasing labor costs are also a concern, as is an estimated "tightening labor supply" in the medical services industry looms.

AMN Healthcare closed Monday trading down 0.40 percent at $37.26.


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Analyst ColorLong IdeasHealth CarePrice TargetAnalyst RatingsTrading IdeasGeneralReal EstateAvondale PartnerRandle Reece